Cancer Biomarkers

Cancer biomarkers, particular those associated with genetic mutations or epigenetic alterations, often offer a quantitative way to determine when individuals are predisposed to particular types of cancers. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.

    Related Conference of Cancer Biomarkers

    June 20-21, 2018

    15th European Pathology Congress

    | Paris, France
    August 29-30, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA
    August 31 - September 01, 2018

    International Conference and Expo on Dermatopathology and Skin Care

    Toronto, Canada
    September 17-18, 2018

    16th Annual Conference on Laboratory Medicine & Pathology

    Abu Dhabi, UAE
    September 17-18, 2018

    16th Asia Pacific Pathology Congress

    Tokyo, Japan
    October 18-19, 2018

    Biology and Pathology of Infectious Disease Conference

    Helsinki, Finland
    October 26-27, 2018

    1st World Congress on Precision Medicine

    Boston, Massachusetts, USA
    December 03-04, 2018

    15th Congress on Pathology and Cancer Research

    Chicago, USA
    March 22-23, 2019 |

    World Birth Congress

    New York, USA
    (14 Forums, 2 Days, 1 Event)

    Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in